GISELE Trademark

Trademark Overview

On Tuesday, January 4, 2011, a trademark application was filed for GISELE with the United States Patent and Trademark Office. The USPTO has given the GISELE trademark a serial number of 85209885. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 22, 2014. This trademark is owned by Glaxo Group Limited. The GISELE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
gisele

General Information

Serial Number85209885
Word MarkGISELE
Filing DateTuesday, January 4, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 22, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Name/Portrait Description and/or Consent StatementThe name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 18, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, September 22, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 22, 2014ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 27, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 26, 2014EXTENSION 5 GRANTED
Tuesday, February 11, 2014EXTENSION 5 FILED
Tuesday, February 11, 2014TEAS EXTENSION RECEIVED
Wednesday, September 4, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2013EXTENSION 4 GRANTED
Tuesday, August 13, 2013EXTENSION 4 FILED
Tuesday, August 13, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 5, 2013EXTENSION 3 GRANTED
Monday, February 4, 2013EXTENSION 3 FILED
Monday, February 4, 2013TEAS EXTENSION RECEIVED
Thursday, August 23, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 22, 2012EXTENSION 2 GRANTED
Tuesday, August 14, 2012EXTENSION 2 FILED
Wednesday, August 22, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 14, 2012TEAS EXTENSION RECEIVED
Friday, January 27, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 25, 2012EXTENSION 1 GRANTED
Wednesday, January 25, 2012EXTENSION 1 FILED
Wednesday, January 25, 2012TEAS EXTENSION RECEIVED
Tuesday, August 16, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 21, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2011PUBLISHED FOR OPPOSITION
Wednesday, May 18, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 18, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 18, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 18, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 9, 2011ASSIGNED TO LIE
Monday, May 9, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 19, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 19, 2011NON-FINAL ACTION E-MAILED
Tuesday, April 19, 2011NON-FINAL ACTION WRITTEN
Tuesday, April 19, 2011REMOVED FROM TEAS PLUS
Monday, April 18, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 18, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 18, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 21, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 21, 2011NON-FINAL ACTION E-MAILED
Monday, March 21, 2011NON-FINAL ACTION WRITTEN
Monday, March 21, 2011ASSIGNED TO EXAMINER
Friday, January 7, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 7, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

gisele pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological